These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 26809073)
1. Structural requirements for potential HIV-integrase inhibitors identified using pharmacophore-based virtual screening and molecular dynamics studies. Islam MA; Pillay TS Mol Biosyst; 2016 Mar; 12(3):982-93. PubMed ID: 26809073 [TBL] [Abstract][Full Text] [Related]
2. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification. Islam MA; Pillay TS J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527 [TBL] [Abstract][Full Text] [Related]
3. Discovery of HIV-1 integrase inhibitors: pharmacophore mapping, virtual screening, molecular docking, synthesis, and biological evaluation. Bhatt H; Patel P; Pannecouque C Chem Biol Drug Des; 2014 Feb; 83(2):154-66. PubMed ID: 23957390 [TBL] [Abstract][Full Text] [Related]
4. New scaffolds of natural origin as Integrase-LEDGF/p75 interaction inhibitors: virtual screening and activity assays. De Luca L; Morreale F; Christ F; Debyser Z; Ferro S; Gitto R Eur J Med Chem; 2013 Oct; 68():405-11. PubMed ID: 23994868 [TBL] [Abstract][Full Text] [Related]
5. Development of a receptor model for efficient in silico screening of HIV-1 integrase inhibitors. Quevedo MA; Ribone SR; Briñón MC; Dehaen W J Mol Graph Model; 2014 Jul; 52():82-90. PubMed ID: 25023663 [TBL] [Abstract][Full Text] [Related]
6. Molecular Docking and Molecular Dynamics Simulation Based Approach to Explore the Dual Inhibitor Against HIV-1 Reverse Transcriptase and Integrase. Chander S; Pandey RK; Penta A; Choudhary BS; Sharma M; Malik R; Prajapati VK; Murugesan S Comb Chem High Throughput Screen; 2017; 20(8):734-746. PubMed ID: 28641512 [TBL] [Abstract][Full Text] [Related]
7. β-secretase inhibitors for Alzheimer's disease: identification using pharmacoinformatics. Islam MA; Pillay TS J Biomol Struct Dyn; 2019 Feb; 37(2):503-522. PubMed ID: 29388503 [TBL] [Abstract][Full Text] [Related]
8. Pharmacophore development and docking studies of the hiv-1 integrase inhibitors derived from N-methylpyrimidones, Dihydroxypyrimidines, and bicyclic pyrimidinones. Telvekar VN; Patel KN Chem Biol Drug Des; 2011 Jul; 78(1):150-60. PubMed ID: 21518263 [TBL] [Abstract][Full Text] [Related]
9. Discovery of HIV-1 integrase inhibitors by pharmacophore searching. Hong H; Neamati N; Wang S; Nicklaus MC; Mazumder A; Zhao H; Burke TR; Pommier Y; Milne GW J Med Chem; 1997 Mar; 40(6):930-6. PubMed ID: 9083481 [TBL] [Abstract][Full Text] [Related]
10. Efficient 3D database screening for novel HIV-1 IN inhibitors. Barreca ML; Rao A; De Luca L; Zappalà M; Gurnari C; Monforte P; De Clercq E; Van Maele B; Debyser Z; Witvrouw M; Briggs JM; Chimirri A J Chem Inf Comput Sci; 2004; 44(4):1450-5. PubMed ID: 15272853 [TBL] [Abstract][Full Text] [Related]
11. De novo design based identification of potential HIV-1 integrase inhibitors: A pharmacoinformatics study. Shinde PB; Bhowmick S; Alfantoukh E; Patil PC; Wabaidur SM; Chikhale RV; Islam MA Comput Biol Chem; 2020 Oct; 88():107319. PubMed ID: 32801062 [TBL] [Abstract][Full Text] [Related]
12. Rational design of 2-pyrrolinones as inhibitors of HIV-1 integrase. Ma K; Wang P; Fu W; Wan X; Zhou L; Chu Y; Ye D Bioorg Med Chem Lett; 2011 Nov; 21(22):6724-7. PubMed ID: 21996518 [TBL] [Abstract][Full Text] [Related]
13. Novel 4-Oxo-4,10-dihydrobenzo[4,5]imidazo[1,2-a]pyrimidine-3-carboxylic Acid Derivatives as HIV-1 Integrase Inhibitors: Synthesis, Docking Studies, Molecular Dynamics Simulation and Biological Activities. Zadeh EE; Vahabpour R; Beirami AD; Hajimahdi Z; Zarghi A Med Chem; 2021; 17(9):1060-1071. PubMed ID: 32901587 [TBL] [Abstract][Full Text] [Related]
14. An effective HIV-1 integrase inhibitor screening platform: Rationality validation of drug screening, conformational mobility and molecular recognition analysis for PFV integrase complex with viral DNA. Du W; Zuo K; Sun X; Liu W; Yan X; Liang L; Wan H; Chen F; Hu J J Mol Graph Model; 2017 Nov; 78():96-109. PubMed ID: 29055187 [TBL] [Abstract][Full Text] [Related]
15. Study on the interactions between diketo-acid inhibitors and prototype foamy virus integrase-DNA complex via molecular docking and comparative molecular dynamics simulation methods. Hu JP; He HQ; Tang DY; Sun GF; Zhang YQ; Fan J; Chang S J Biomol Struct Dyn; 2013; 31(7):734-47. PubMed ID: 22913375 [TBL] [Abstract][Full Text] [Related]
16. Discovery of a novel HIV-1 integrase inhibitor from natural compounds through structure based virtual screening and cell imaging. Gu WG; Zhang X; Ip DT; Yang LM; Zheng YT; Wan DC FEBS Lett; 2014 Sep; 588(18):3461-8. PubMed ID: 25128456 [TBL] [Abstract][Full Text] [Related]
17. Identification of potential HIV-1 integrase strand transfer inhibitors: in silico virtual screening and QM/MM docking studies. Reddy KK; Singh SK; Tripathi SK; Selvaraj C SAR QSAR Environ Res; 2013; 24(7):581-95. PubMed ID: 23521430 [TBL] [Abstract][Full Text] [Related]
18. Exploring binding mode for styrylquinoline HIV-1 integrase inhibitors using comparative molecular field analysis and docking studies. Ma XH; Zhang XY; Tan JJ; Chen WZ; Wang CX Acta Pharmacol Sin; 2004 Jul; 25(7):950-8. PubMed ID: 15210071 [TBL] [Abstract][Full Text] [Related]
19. The design of potent HIV-1 integrase inhibitors by a combined approach of structure-based virtual screening and molecular dynamics simulation. Samorlu AS; Yelekçi K; Ibrahim Uba A J Biomol Struct Dyn; 2019 Oct; 37(17):4644-4650. PubMed ID: 30526403 [TBL] [Abstract][Full Text] [Related]
20. Pharmacophore modelling and atom-based 3D-QSAR studies on N-methyl pyrimidones as HIV-1 integrase inhibitors. Reddy KK; Singh SK; Dessalew N; Tripathi SK; Selvaraj C J Enzyme Inhib Med Chem; 2012 Jun; 27(3):339-47. PubMed ID: 21699459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]